H.G. Beger
Impact in
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research
- Cancer-related Molecular Pathways
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
Papers in
- Co-authors
- F. Safi (2 shared papers)Ingrid Köhler (1 shared paper)E. Röttinger (1 shared paper)Marko Kornmann (2 shared papers)M. H. Schoenberg (2 shared papers)MW Büchler (1 shared paper)Murray Korc (1 shared paper)Nadir Arber (1 shared paper)
- Journals
- Pancreas (3 papers)European Journal of Cancer (2 papers)Gastroenterology (2 papers)Cancer (1 paper)Clinical Nutrition (1 paper)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
H.G. Beger
18 papers receiving 443 citations
Peers
Comparison fields: 5 of 74
- Oncology 240
- Cancer Research 63
- Surgery 166
- Hepatology 19
- Molecular Biology 151
Countries citing papers authored by H.G. Beger
This map shows the geographic impact of H.G. Beger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H.G. Beger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H.G. Beger more than expected).
Fields of papers citing papers by H.G. Beger
This network shows the impact of papers produced by H.G. Beger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H.G. Beger. The network helps show where H.G. Beger may publish in the future.
Co-authors
The 25 scholars most cited alongside H.G. Beger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1991 | 117 | |
| 2 | Inhibition of cyclin D1 expression in human pancreatic cancer cells is associated with increased chemosensitivity and decreased expression of multiple chemoresistance genes. | 1999 | 104 |
| 3 | Oxygen radicals in experimental acute pancreatitis. | 1994 | 70 |
| 4 | 2002 | 58 | |
| 5 | Oxaliplatin exerts potent in vitro cytotoxicity in colorectal and pancreatic cancer cell lines and liver metastases. | 2000 | 40 |
| 6 | 1992 | 25 | |
| 7 | 1992 | 12 | |
| 8 | 1996 | 10 | |
| 9 | 1975 | 6 | |
| 10 | 2001 | 3 | |
| 11 | 2004 | 3 | |
| 12 | 1990 | 2 | |
| 13 | 1998 | 2 | |
| 14 | 2001 | 2 | |
| 15 | 1996 | 1 | |
| 16 | 1997 | 1 | |
| 17 | 2004 | 1 | |
| 18 | 1983 | 1 |
About H.G. Beger
H.G. Beger is a scholar working on Surgery, Oncology, Molecular Biology, Pulmonary and Respiratory Medicine and Epidemiology, having authored 18 papers that have together received 458 indexed citations. Recurring topics across this work include Pancreatitis Pathology and Treatment (8 papers), Pancreatic and Hepatic Oncology Research (6 papers), Neuroendocrine Tumor Research Advances (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Cancer Genomics and Diagnostics (2 papers), Abdominal vascular conditions and treatments (2 papers), Renal cell carcinoma treatment (2 papers) and Cancer Treatment and Pharmacology (1 paper). The work is most often cited by research in Oncology (240 citations), Cancer Research (63 citations), Surgery (166 citations), Hepatology (19 citations) and Molecular Biology (151 citations). H.G. Beger has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include F. Safi, Ingrid Köhler, E. Röttinger, Marko Kornmann, M. H. Schoenberg, MW Büchler, Murray Korc, Nadir Arber, Kathleen D. Danenberg and P. V. Danenberg. Their work appears in journals such as Pancreas, European Journal of Cancer, Gastroenterology, Cancer and Clinical Nutrition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.